The global market for Children Influenza Vaccine was estimated to be worth US$ 1597 million in 2023 and is forecast to a readjusted size of US$ 2090.9 million by 2030 with a CAGR of 3.9% during the forecast period 2024-2030

Children Influenza Vaccine - Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Children Influenza Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Children Influenza Vaccine by region & country, by Type, and by Application.

The Children Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Influenza Vaccine.

Market Segmentation

Scope of Children Influenza Vaccine - Market Report

Report Metric	Details
Report Name	Children Influenza Vaccine - Market
Forecasted market size in 2030	US$ 2090.9 million
CAGR	3.9%
Forecasted years	2024 - 2030
Segment by Type:	Nasal Spray Injection
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, CSL, GSK, Viatris, Hulan Bio, AstraZeneca, CCBIO, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Children Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Children Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Children Influenza Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Children Influenza Vaccine - Market size in 2030?

Ans: The Children Influenza Vaccine - Market size in 2030 will be US$ 2090.9 million.

Who are the main players in the Children Influenza Vaccine - Market report?

Ans: The main players in the Children Influenza Vaccine - Market are Sanofi, CSL, GSK, Viatris, Hulan Bio, AstraZeneca, CCBIO, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Children Influenza Vaccine - Market report?

Ans: The Applications covered in the Children Influenza Vaccine - Market report are Public, Private

What are the Type segmentation covered in the Children Influenza Vaccine - Market report?

Ans: The Types covered in the Children Influenza Vaccine - Market report are Nasal Spray, Injection

1 Market Overview

1.1 Children Influenza Vaccine Product Introduction

1.2 Global Children Influenza Vaccine Market Size Forecast

1.2.1 Global Children Influenza Vaccine Sales Value (2019-2030)

1.2.2 Global Children Influenza Vaccine Sales Volume (2019-2030)

1.2.3 Global Children Influenza Vaccine Sales Price (2019-2030)

1.3 Children Influenza Vaccine Market Trends & Drivers

1.3.1 Children Influenza Vaccine Industry Trends

1.3.2 Children Influenza Vaccine Market Drivers & Opportunity

1.3.3 Children Influenza Vaccine Market Challenges

1.3.4 Children Influenza Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Children Influenza Vaccine Players Revenue Ranking (2023)

2.2 Global Children Influenza Vaccine Revenue by Company (2019-2024)

2.3 Global Children Influenza Vaccine Players Sales Volume Ranking (2023)

2.4 Global Children Influenza Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Children Influenza Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Children Influenza Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Children Influenza Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Children Influenza Vaccine

2.9 Children Influenza Vaccine Market Competitive Analysis

2.9.1 Children Influenza Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Children Influenza Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Influenza Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Nasal Spray

3.1.2 Injection

3.2 Global Children Influenza Vaccine Sales Value by Type

3.2.1 Global Children Influenza Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Children Influenza Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Children Influenza Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Children Influenza Vaccine Sales Volume by Type

3.3.1 Global Children Influenza Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Children Influenza Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Children Influenza Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Children Influenza Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Public

4.1.2 Private

4.2 Global Children Influenza Vaccine Sales Value by Application

4.2.1 Global Children Influenza Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Children Influenza Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Children Influenza Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Children Influenza Vaccine Sales Volume by Application

4.3.1 Global Children Influenza Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Children Influenza Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Children Influenza Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Children Influenza Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Children Influenza Vaccine Sales Value by Region

5.1.1 Global Children Influenza Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Children Influenza Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Children Influenza Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Children Influenza Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Children Influenza Vaccine Sales Volume by Region

5.2.1 Global Children Influenza Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Children Influenza Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Children Influenza Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Children Influenza Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Children Influenza Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Children Influenza Vaccine Sales Value, 2019-2030

5.4.2 North America Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Children Influenza Vaccine Sales Value, 2019-2030

5.5.2 Europe Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Children Influenza Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Children Influenza Vaccine Sales Value, 2019-2030

5.7.2 South America Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Children Influenza Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Children Influenza Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Children Influenza Vaccine Sales Value

6.2.1 Key Countries/Regions Children Influenza Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Children Influenza Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Children Influenza Vaccine Sales Value, 2019-2030

6.3.2 United States Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Children Influenza Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Children Influenza Vaccine Sales Value, 2019-2030

6.4.2 Europe Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Children Influenza Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Children Influenza Vaccine Sales Value, 2019-2030

6.5.2 China Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Children Influenza Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Children Influenza Vaccine Sales Value, 2019-2030

6.6.2 Japan Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Children Influenza Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Children Influenza Vaccine Sales Value, 2019-2030

6.7.2 South Korea Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Children Influenza Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Children Influenza Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Children Influenza Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Children Influenza Vaccine Sales Value, 2019-2030

6.9.2 India Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Children Influenza Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi

7.1.1 Sanofi Company Information

7.1.2 Sanofi Introduction and Business Overview

7.1.3 Sanofi Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Children Influenza Vaccine Product Offerings

7.1.5 Sanofi Recent Development

7.2 CSL

7.2.1 CSL Company Information

7.2.2 CSL Introduction and Business Overview

7.2.3 CSL Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CSL Children Influenza Vaccine Product Offerings

7.2.5 CSL Recent Development

7.3 GSK

7.3.1 GSK Company Information

7.3.2 GSK Introduction and Business Overview

7.3.3 GSK Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 GSK Children Influenza Vaccine Product Offerings

7.3.5 GSK Recent Development

7.4 Viatris

7.4.1 Viatris Company Information

7.4.2 Viatris Introduction and Business Overview

7.4.3 Viatris Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Viatris Children Influenza Vaccine Product Offerings

7.4.5 Viatris Recent Development

7.5 Hulan Bio

7.5.1 Hulan Bio Company Information

7.5.2 Hulan Bio Introduction and Business Overview

7.5.3 Hulan Bio Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Hulan Bio Children Influenza Vaccine Product Offerings

7.5.5 Hulan Bio Recent Development

7.6 AstraZeneca

7.6.1 AstraZeneca Company Information

7.6.2 AstraZeneca Introduction and Business Overview

7.6.3 AstraZeneca Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 AstraZeneca Children Influenza Vaccine Product Offerings

7.6.5 AstraZeneca Recent Development

7.7 CCBIO

7.7.1 CCBIO Company Information

7.7.2 CCBIO Introduction and Business Overview

7.7.3 CCBIO Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 CCBIO Children Influenza Vaccine Product Offerings

7.7.5 CCBIO Recent Development

7.8 Sinovac

7.8.1 Sinovac Company Information

7.8.2 Sinovac Introduction and Business Overview

7.8.3 Sinovac Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Sinovac Children Influenza Vaccine Product Offerings

7.8.5 Sinovac Recent Development

7.9 BCHT

7.9.1 BCHT Company Information

7.9.2 BCHT Introduction and Business Overview

7.9.3 BCHT Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 BCHT Children Influenza Vaccine Product Offerings

7.9.5 BCHT Recent Development

7.10 Jiangsu GDK

7.10.1 Jiangsu GDK Company Information

7.10.2 Jiangsu GDK Introduction and Business Overview

7.10.3 Jiangsu GDK Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Jiangsu GDK Children Influenza Vaccine Product Offerings

7.10.5 Jiangsu GDK Recent Development

7.11 KM Biologics

7.11.1 KM Biologics Company Information

7.11.2 KM Biologics Introduction and Business Overview

7.11.3 KM Biologics Children Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 KM Biologics Children Influenza Vaccine Product Offerings

7.11.5 KM Biologics Recent Development

8 Industry Chain Analysis

8.1 Children Influenza Vaccine Industrial Chain

8.2 Children Influenza Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Children Influenza Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Children Influenza Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Children Influenza Vaccine Market Trends

Table 2. Children Influenza Vaccine Market Drivers & Opportunity

Table 3. Children Influenza Vaccine Market Challenges

Table 4. Children Influenza Vaccine Market Restraints

Table 5. Global Children Influenza Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Children Influenza Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Children Influenza Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Children Influenza Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Children Influenza Vaccine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Children Influenza Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Children Influenza Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Children Influenza Vaccine

Table 13. Global Children Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Influenza Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Children Influenza Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Children Influenza Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Children Influenza Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Children Influenza Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Children Influenza Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Children Influenza Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Children Influenza Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Children Influenza Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Children Influenza Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Children Influenza Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Children Influenza Vaccine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Children Influenza Vaccine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Children Influenza Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Children Influenza Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Children Influenza Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Children Influenza Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Children Influenza Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Children Influenza Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Children Influenza Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Children Influenza Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Children Influenza Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Children Influenza Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Children Influenza Vaccine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Children Influenza Vaccine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Children Influenza Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Children Influenza Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Children Influenza Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Children Influenza Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Children Influenza Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Children Influenza Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Children Influenza Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Children Influenza Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Children Influenza Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Children Influenza Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Children Influenza Vaccine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Children Influenza Vaccine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Children Influenza Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Children Influenza Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Children Influenza Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Children Influenza Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Children Influenza Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Sanofi Company Information

Table 58. Sanofi Introduction and Business Overview

Table 59. Sanofi Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Sanofi Children Influenza Vaccine Product Offerings

Table 61. Sanofi Recent Development

Table 62. CSL Company Information

Table 63. CSL Introduction and Business Overview

Table 64. CSL Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. CSL Children Influenza Vaccine Product Offerings

Table 66. CSL Recent Development

Table 67. GSK Company Information

Table 68. GSK Introduction and Business Overview

Table 69. GSK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. GSK Children Influenza Vaccine Product Offerings

Table 71. GSK Recent Development

Table 72. Viatris Company Information

Table 73. Viatris Introduction and Business Overview

Table 74. Viatris Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Viatris Children Influenza Vaccine Product Offerings

Table 76. Viatris Recent Development

Table 77. Hulan Bio Company Information

Table 78. Hulan Bio Introduction and Business Overview

Table 79. Hulan Bio Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Hulan Bio Children Influenza Vaccine Product Offerings

Table 81. Hulan Bio Recent Development

Table 82. AstraZeneca Company Information

Table 83. AstraZeneca Introduction and Business Overview

Table 84. AstraZeneca Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. AstraZeneca Children Influenza Vaccine Product Offerings

Table 86. AstraZeneca Recent Development

Table 87. CCBIO Company Information

Table 88. CCBIO Introduction and Business Overview

Table 89. CCBIO Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. CCBIO Children Influenza Vaccine Product Offerings

Table 91. CCBIO Recent Development

Table 92. Sinovac Company Information

Table 93. Sinovac Introduction and Business Overview

Table 94. Sinovac Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Sinovac Children Influenza Vaccine Product Offerings

Table 96. Sinovac Recent Development

Table 97. BCHT Company Information

Table 98. BCHT Introduction and Business Overview

Table 99. BCHT Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. BCHT Children Influenza Vaccine Product Offerings

Table 101. BCHT Recent Development

Table 102. Jiangsu GDK Company Information

Table 103. Jiangsu GDK Introduction and Business Overview

Table 104. Jiangsu GDK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Jiangsu GDK Children Influenza Vaccine Product Offerings

Table 106. Jiangsu GDK Recent Development

Table 107. KM Biologics Company Information

Table 108. KM Biologics Introduction and Business Overview

Table 109. KM Biologics Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. KM Biologics Children Influenza Vaccine Product Offerings

Table 111. KM Biologics Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Children Influenza Vaccine Downstream Customers

Table 115. Children Influenza Vaccine Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Children Influenza Vaccine Product Picture

Figure 2. Global Children Influenza Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Children Influenza Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Children Influenza Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Children Influenza Vaccine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Children Influenza Vaccine Report Years Considered

Figure 7. Global Children Influenza Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Children Influenza Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Children Influenza Vaccine Revenue in 2023

Figure 10. Children Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Nasal Spray Picture

Figure 12. Injection Picture

Figure 13. Global Children Influenza Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Children Influenza Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Children Influenza Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Children Influenza Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Children Influenza Vaccine Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Public

Figure 19. Product Picture of Private

Figure 20. Global Children Influenza Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Children Influenza Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Children Influenza Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Children Influenza Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Children Influenza Vaccine Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Children Influenza Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Children Influenza Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Children Influenza Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Children Influenza Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Children Influenza Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Children Influenza Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Children Influenza Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Children Influenza Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Children Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Children Influenza Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Children Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Children Influenza Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Children Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Children Influenza Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Children Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Children Influenza Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Children Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Children Influenza Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Children Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Children Influenza Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Children Influenza Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Children Influenza Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Children Influenza Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Children Influenza Vaccine Industrial Chain

Figure 59. Children Influenza Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions